Market Overview:
The global terazosin hydrochloride (CAS 63074-08-8) market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as an increase in the prevalence of hypertension, rising geriatric population, and increasing demand for terazosin hydrochloride (CAS 63074-08-8) from hospitals and retail pharmacies. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global terazosin hydrochloride (CAS 63074-08-8) market can be segmented into 1mg/tablet, 2mg/tablet, and 5mg/tablet segments. Based on application, it can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies segments.
 Industry Outlook.svg)
Product Definition:
Terazosin hydrochloride is a selective alpha1-adrenergic blocker used to treat hypertension and benign prostatic hyperplasia. It competitively inhibits the action of norepinephrine at postsynaptic alpha1-adrenergic receptors in vascular smooth muscle and in the prostate, leading to vasodilation and decreased prostate size, respectively.
1mg/Tablet:
1mg/Tablet, it's usage and growth factor in Terazosin Hydrochloride (CAS 63074-08-8) market is driven by the growing prevalence of hypertension globally. Hypertension increases the risk of cardiovascular diseases and stroke. According to WHO, more than 1 billion people worldwide have hypertension.
2mg/Tablet:
2mg/Tablet is a generic name for the drug Terazosin Hydrochloride. It is also known as N-Ethyl-2-methylpropanamide hydrochloride. 2mg/Tablet is a white crystalline solid and has a mild odor. It freely soluble in water and has an acidic taste.
Application Insights:
The retail pharmacies segment held the largest share of over 70.0% in 2017. This is attributed to growing awareness about health and rising incidences of hypertension among adults. In addition, increasing availability of tablets at affordable prices through online pharmacies is expected to drive the demand for HTZ throughout the forecast period.
Online pharmacy sales are projected to grow significantly over the coming years owing to various benefits offered including convenience, flexibility and accessibility along with security and privacy provided by terazosin hydrochloride online pharmacy stores. The growth of e-commerce has resulted in an increased number of online pharma retailers which can be beneficial for market growth as it provides them a wider customer base from where they can learn about new products/services offered by competitors which may result in additional purchases or subscriptions towards their preferred brands/brands only if they provide better quality products at lower costs thereby driving overall market growth during the forecast period from 2018 to 2030 .
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure, favorable reimbursement policies, and increasing geriatric population are some factors attributing to its largest share. In addition, the region is anticipated to witness growth owing to rising awareness regarding HTN disorders such as hypertension and atherosclerosis among consumers.
Asia Pacific is expected to be one of the fastest-growing regions over the forecast period due to rapid economic development along with improving healthcare infrastructure in emerging countries such as China & India & Japan etcetera; which has led towards an increase in demand for various pharmaceutical products including terazosin hydrochloride tablets over this period. Moreover, growing medical tourism industry will also contribute towards regional growth during this period.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for terazosin hydrochloride in the coming years.
- Rising prevalence of hypertension: The prevalence of hypertension is on the rise globally and this is expected to boost the demand for terazosin hydrochloride in the near future.
- Growing awareness about hypertension: There has been a significant increase in awareness about hypertension among people across the globe in recent years. This is likely to fuel demand for terazosin hydrochloride in the coming years.
- Technological advancements: The development of new and innovative therapies using terazosin hydrochloride will help propel growth of this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Terazosin Hydrochloride (CAS 63074-08-8) Market Research Report
By Type
1mg/Tablet, 2mg/Tablet, 5mg/Tablet
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Yiyang Pharma, Changzhou Pharma, Abbott, Yatai Pharma, Ruikang Pharma, Dongxin Pharma, Kedi Pharma, Lingyuan Pharma, Dongrui Pharma, Shanghai Yanan Pharma, Qilu Pharma, Tangtze River Pharma, Jubilant Cadista, Intas Pharma, Accord Healthcare, CMG Pharma, TEVA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Terazosin Hydrochloride (CAS 63074-08-8) Market Report Segments:
The global Terazosin Hydrochloride (CAS 63074-08-8) market is segmented on the basis of:
Types
1mg/Tablet, 2mg/Tablet, 5mg/Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Yiyang Pharma
- Changzhou Pharma
- Abbott
- Yatai Pharma
- Ruikang Pharma
- Dongxin Pharma
- Kedi Pharma
- Lingyuan Pharma
- Dongrui Pharma
- Shanghai Yanan Pharma
- Qilu Pharma
- Tangtze River Pharma
- Jubilant Cadista
- Intas Pharma
- Accord Healthcare
- CMG Pharma
- TEVA
 Market Overview.svg)
Highlights of The Terazosin Hydrochloride (CAS 63074-08-8) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mg/Tablet
- 2mg/Tablet
- 5mg/Tablet
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Terazosin Hydrochloride (CAS 63074-08-8) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Terazosin hydrochloride is a medication used to treat hypertension. It works by relaxing blood vessels and decreasing blood pressure.
Some of the major players in the terazosin hydrochloride (cas 63074-08-8) market are Yiyang Pharma, Changzhou Pharma, Abbott, Yatai Pharma, Ruikang Pharma, Dongxin Pharma, Kedi Pharma, Lingyuan Pharma, Dongrui Pharma, Shanghai Yanan Pharma, Qilu Pharma, Tangtze River Pharma, Jubilant Cadista, Intas Pharma, Accord Healthcare, CMG Pharma, TEVA.
The terazosin hydrochloride (cas 63074-08-8) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Terazosin Hydrochloride (CAS 63074-08-8) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Terazosin Hydrochloride (CAS 63074-08-8) Market - Supply Chain
4.5. Global Terazosin Hydrochloride (CAS 63074-08-8) Market Forecast
4.5.1. Terazosin Hydrochloride (CAS 63074-08-8) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Terazosin Hydrochloride (CAS 63074-08-8) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Absolute $ Opportunity
5. Global Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
5.3.1. 1mg/Tablet
5.3.2. 2mg/Tablet
5.3.3. 5mg/Tablet
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Terazosin Hydrochloride (CAS 63074-08-8) Demand Share Forecast, 2019-2026
9. North America Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
9.7.1. 1mg/Tablet
9.7.2. 2mg/Tablet
9.7.3. 5mg/Tablet
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Terazosin Hydrochloride (CAS 63074-08-8) Demand Share Forecast, 2019-2026
10. Latin America Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
10.7.1. 1mg/Tablet
10.7.2. 2mg/Tablet
10.7.3. 5mg/Tablet
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Terazosin Hydrochloride (CAS 63074-08-8) Demand Share Forecast, 2019-2026
11. Europe Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
11.7.1. 1mg/Tablet
11.7.2. 2mg/Tablet
11.7.3. 5mg/Tablet
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Terazosin Hydrochloride (CAS 63074-08-8) Demand Share, 2019-2026
12. Asia Pacific Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
12.7.1. 1mg/Tablet
12.7.2. 2mg/Tablet
12.7.3. 5mg/Tablet
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Terazosin Hydrochloride (CAS 63074-08-8) Demand Share, 2019-2026
13. Middle East & Africa Terazosin Hydrochloride (CAS 63074-08-8) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Terazosin Hydrochloride (CAS 63074-08-8) Market Size and Volume Forecast by Type
13.7.1. 1mg/Tablet
13.7.2. 2mg/Tablet
13.7.3. 5mg/Tablet
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Terazosin Hydrochloride (CAS 63074-08-8) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Terazosin Hydrochloride (CAS 63074-08-8) Market: Market Share Analysis
14.2. Terazosin Hydrochloride (CAS 63074-08-8) Distributors and Customers
14.3. Terazosin Hydrochloride (CAS 63074-08-8) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Yiyang Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Changzhou Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Yatai Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ruikang Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dongxin Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Kedi Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lingyuan Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Dongrui Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Shanghai Yanan Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Qilu Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Tangtze River Pharma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Jubilant Cadista
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Intas Pharma
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Accord Healthcare
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. CMG Pharma
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. TEVA
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
